Aussie medical tech scores big win in US market
Cyclopharm’s lung imaging technology is breathing new life into the company’s bottom line, with its Technegas product surpassing the million-dollar milestone in US sales, according to Tuesday’s ASX announcement. The Sydney-based company has rapidly expanded its American footprint, with Technegas systems now installed in 27 US medical facilities as of 31 March 2025 – a…